Fmoc-L-Cys(Phacm)-OH

Fmoc-L-Cys(Phacm)-OH is an Fmoc-protected L-cysteine derivative bearing a Phacm (phenylacetamidomethyl) thioether protecting group on the side-chain thiol. The molecule combines an N-(9H-fluoren-9-ylmethoxycarbonyl) group for solid-phase and solution-phase peptide coupling control with a stereodefined L-amino acid backbone (single chiral center at the alpha-carbon) suitable for stereochemically consistent incorporation. The carboxylic acid remains available for activation to form amide bonds, while the Phacm-protected sulfur is designed to tolerate peptide assembly conditions and can be selectively removed under thiol-deprotection workflows to regenerate a reactive cysteine side chain. The presence of the thioether-protecting group and the Fmoc carbamate architecture makes the compound a practical chiral amino acid intermediate for downstream peptide synthesis and cysteine-functional derivative construction.

1. Protected Cysteine Peptide Synthesis

Fmoc-L-Cys(Phacm)-OH is applied in peptide building block preparation where controlled cysteine chemistry is required during chain assembly. The Fmoc group protects the alpha-amino functionality for iterative peptide coupling, while the carboxylic acid enables activation to form amide linkages and the Phacm group suppresses undesired thiol reactivity during coupling and deprotection cycles. Selective Phacm removal can regenerate the cysteine thiol for subsequent disulfide formation, thiol alkylation, or conjugation steps after peptide assembly. Peptide science workflows can therefore use this protected amino acid to construct cysteine-containing sequences with minimized side reactions and stereochemically faithful incorporation.

2. Thiol Functionalization And Conjugation

Fmoc-L-Cys(Phacm)-OH supports chemical biology and biomolecule modification strategies that require a protected thiol handle for later-stage functionalization. The side-chain sulfur is masked as a Phacm-protected thioether during synthesis, reducing oxidation and preventing premature crosslinking, while the regenerated thiol after deprotection can participate in nucleophilic substitution, Michael-type additions, or disulfide exchange depending on the electrophile or oxidant used. The Fmoc-protected N-terminus and free carboxyl group also facilitate conversion into activated intermediates for attaching cysteine-bearing motifs to peptides, linkers, or surfaces. Downstream conjugate generation can be integrated into workflows for producing cysteine-functional probes, affinity reagents, and chemically defined bioconjugates.

3. Peptidomimetic And SAR Studies

Fmoc-L-Cys(Phacm)-OH is used in peptidomimetic construction and structure-activity relationship studies where cysteine side-chain positioning influences binding and reactivity profiles. The chiral L-cysteine framework provides a stereodefined scaffold for incorporation into peptide analogs, while the protected thiol enables controlled late-stage diversification without disrupting earlier synthetic steps. The carboxylic acid and Fmoc-protected amine support standard amide coupling chemistry to assemble analog series, and the Phacm group allows orthogonal timing of thiol unveiling relative to other functional groups present in the target scaffold. Molecular design efforts can thus generate cysteine-bearing analogs suitable for comparative SAR experiments and for mapping how thiol availability affects molecular recognition and stability.

4. Process Chemistry Intermediate Preparation

Fmoc-L-Cys(Phacm)-OH is suitable for process chemistry intermediate preparation in fine chemical manufacturing where orthogonally protected amino acids streamline route design. The Fmoc carbamate and Phacm thio-protection strategy provide a controlled protection/deprotection logic that can be aligned with scalable peptide coupling operations and downstream cysteine-releasing steps. The molecule's defined functional group set, including an acid for activation and a protected amine for selective deprotection, supports conversion into standardized intermediates used across multi-step synthesis campaigns. Industrial teams can employ this chiral amino acid derivative to prepare cysteine-containing fragments and peptide building blocks with predictable handling characteristics during manufacturing of research-grade peptides and related specialty chemicals.

5. Analytical Standards And Method Development

Fmoc-L-Cys(Phacm)-OH can serve as an analytical reference material and method development substrate for monitoring protected amino acid handling and cysteine deprotection performance. The presence of the Fmoc chromophore and the distinct Phacm-protected thioether provides characteristic chromatographic and spectroscopic signatures that can be used to verify identity, track protection integrity, and evaluate conversion during peptide synthesis workflows. The defined stereochemistry and functional group pattern support development of LC-MS or HPLC methods for distinguishing cysteine derivatives with different protection states, including thiol-regenerated forms. Analytical research groups can therefore use this compound to support quality control of cysteine-containing intermediates and to improve robustness of analytical assays used in amino acid derivatization programs.

1. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

2. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

4. The spatiotemporal control of signalling and trafficking of the GLP-1R

5. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features